加拿大 -
法文 -
Health Canada
apo-naltrexone comprimé
apotex inc - chlorhydrate de naltrexone - comprimé - 50mg - chlorhydrate de naltrexone 50mg - opiate antagonists
加拿大 -
法文 -
Health Canada
naltrexone hydrochloride tablets usp comprimé
sterinova inc. - chlorhydrate de naltrexone - comprimé - 50mg - chlorhydrate de naltrexone 50mg - opiate antagonists
加拿大 -
法文 -
Health Canada
revia comprimé
teva canada limited - chlorhydrate de naltrexone - comprimé - 50mg - chlorhydrate de naltrexone 50mg - opiate antagonists
欧盟 -
法文 -
EMA (European Medicines Agency)
calquence
astrazeneca ab - acalabrutinib - leucémie, lymphocytaire, chronique, b-cell - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
比利时 -
法文 -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
diclofenac ibsa farmaceutici 140 mg compresse impr.
ibsa farmaceutici italia s.r.l. - diclofénac epolamine 180 mg - eq. diclofénac sodique 139 mg - compresse imprégnée - 140 mg - diclofénac epolamine 180 mg - diclofenac
瑞士 -
法文 -
Swissmedic (Swiss Agency for Therapeutic Products)
calquence 100 mg gélules
astrazeneca ag - acalabrutinibum - gélules - acalabrutinibum 100 mg, cellulosum microcristallinum silicificatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium max. 0.25 mg, magnesii stearas, kapselhülle: gelatina, e 172 (flavum), e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - chronisch lymphatische leukämie (cll) - synthetika
加拿大 -
法文 -
Health Canada
calquence capsule
astrazeneca canada inc - acalabrutinib - capsule - 100mg - acalabrutinib 100mg - antineoplastic agents
加拿大 -
法文 -
Health Canada
calquence comprimé
astrazeneca canada inc - acalabrutinib (maléate d¿acalabrutinib) - comprimé - 100mg - acalabrutinib (maléate d¿acalabrutinib) 100mg
瑞士 -
法文 -
Swissmedic (Swiss Agency for Therapeutic Products)
calquence 100 mg comprimés pelliculés
astrazeneca ag - acalabrutinibum - comprimés pelliculés - acalabrutinibum 100 mg ut acalabrutinibi maleas monohydricum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, natrii stearylis fumaras, Überzug: hypromellosum, copovidonum, e 171, macrogolum 3350, triglycerida media, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.59 mg. - chronisch lymphatische leukämie (cll) - synthetika